tBHQ attenuates podocyte injury in diabetic nephropathy by inhibiting NADPH oxidase-derived ROS generation via the Nrf2/HO-1 signalling pathway

MLA

Ting Liu, et al. “TBHQ Attenuates Podocyte Injury in Diabetic Nephropathy by Inhibiting NADPH Oxidase-Derived ROS Generation via the Nrf2/HO-1 Signalling Pathway.” Heliyon, vol. 8, no. 9, Sept. 2022. EBSCOhost, https://doi.org/10.1016/j.heliyon.2022.e10515.

APA

Ting Liu, Chang-yan Li, Hao Chen, Juan Liu, Li-li Zhong, Ming-min Tang, Wen-bo Wang, Jin-ping Huang, & Xu-shun Jiang. (2022). tBHQ attenuates podocyte injury in diabetic nephropathy by inhibiting NADPH oxidase-derived ROS generation via the Nrf2/HO-1 signalling pathway. Heliyon, 8(9). https://doi.org/10.1016/j.heliyon.2022.e10515

Chicago

Ting Liu, Chang-yan Li, Hao Chen, Juan Liu, Li-li Zhong, Ming-min Tang, Wen-bo Wang, Jin-ping Huang, and Xu-shun Jiang. 2022. “TBHQ Attenuates Podocyte Injury in Diabetic Nephropathy by Inhibiting NADPH Oxidase-Derived ROS Generation via the Nrf2/HO-1 Signalling Pathway.” Heliyon 8 (9). doi:10.1016/j.heliyon.2022.e10515.